michigan semaglutide digestive blockage class action A pilot program will cover weight-loss drugs for millions of Medicare enrollees for the first time beginning July 1. Read more about who's eligible and what medications are included at the link Ozempic GLP-1 Lawsuit & Gastroparesis
Description
Payers and PBMs are the most powerful agents of post-expiry competition
MeAgain helps you log what happened and when, so the conversation has facts instead of memory
yet, unfortunately, there is a scarcity of available pharmacological management options
The $1,092 annual difference is real money
The state obesity drug coverage landscape will continue to evolve as states respond to the recent announcement of the BALANCE model (see Box 1) and as states contend with budget challenges and the federal Medicaid spending cuts in the 2025 reconciliation law
Kessler also wrote that obesity is a metabolic disorder that causes the body to create too much fat tissue
